CEBPZ and acute myeloid leukemia: Similarly, we would suggest to consider MRD persistence after consolidation in cytogenetically favourable AML, such as CBF AML or normal-karyotype wtFLT3 mNPM1 patients, as a very strong indicator for consolidation with allo-HSCT in CR1, but only after a proper assessment of patient status and transplant-risk.